The DOI matches its Crossref record; 67 of the 67 references it cites were found in a registry or an index.
The New Antiepileptic Drugs: Scientific Review
Abstract
CONTEXT: The past decade has brought many advances to the treatment of epilepsy, including many new pharmacological agents. Primary care physicians often care for patients with epilepsy and therefore should be familiar with the new options available. OBJECTIVE: To review data regarding the efficacy and tolerability of antiepileptic drugs introduced in the past decade. DATA SOURCES: A search of the Cochrane Central Register of Controlled Trials was performed to identify all published human and English-language randomized controlled trials evaluating the efficacy and tolerability of the antiepileptic drugs that have been approved for use in the United States since 1990. Additional reports evaluating pharmacokinetic properties were identified through a MEDLINE search as well as review of article bibliographies. STUDY SELECTION AND DATA EXTRACTION: Search terms included felbamate, gabapentin, lamotrigine, topiramate, tiagabine, levetiracetam, oxcarbazepine, and zonisamide. Studies were selected if efficacy and tolerability were reported as major outcome measures. Included studies (n = 55) enrolled a minimum of 20 adult subjects and had a treatment period of at least 6 weeks. DATA SYNTHESIS: Eight new antiepileptic drugs have been approved for use in the United States in the past decade. Each new antiepileptic drug is well tolerated and demonstrates statistically significant reductions in seizure frequency over baseline. No randomized controlled trials have compared the new antiepileptic drugs with each other or against the traditional antiepileptic drugs. Although there is no evidence to suggest that the newer medications are more efficacious, several studies have demonstrated broader spectrum of activity, fewer drug interactions, and overall better tolerability of the new agents. CONCLUSIONS: New antiepileptic drugs offer many options in the treatment of epilepsy, each with unique mechanisms of action as well as adverse effect profiles. The new antiepileptic drugs are well tolerated with few adverse effects, minimal drug interactions, and a broad spectrum of activity.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Early Identification of Refractory Epilepsy
Kwan, P., & Brodie, M. J. (2000) · New England Journal of Medicine · doi:10.1056/nejm200002033420503 · Cited by 5,204
Arky, R. A. (1994) · Cited by 2,632
Severe Adverse Cutaneous Reactions to Drugs
Roujeau, J. C., & Stern, R. S. (1994) · New England Journal of Medicine · doi:10.1056/nejm199411103311906 · Cited by 1,571
Blume, W. T., Lüders, H. O., Mizrahi, E., Tassinari, C., Van Emde Boas, W., & Engel, J. (2001) · Epilepsia · doi:10.1046/j.1528-1157.2001.22001.x · Cited by 865
Prevalence of Epilepsy in Rochester, Minnesota: 1940–1980
Hauser, W. A., Annegers, J. F., & Kurland, L. T. (1991) · Epilepsia · doi:10.1111/j.1528-1157.1991.tb04675.x · Cited by 841
Double-blind comparison of lamotrigine and carbamazepine in newly diagnosed epilepsy
Brodie, M. J., UK Lamotrigine/Carbamazepine Monotherapy Trial Group, Richens, A., & Yuen, A. (1995) · The Lancet · doi:10.1016/s0140-6736(95)90581-2 · Cited by 615
Levetiracetam for partial seizures: Results of a double-blind, randomized clinical trial
Cereghino, J. J., Biton, V., Abou-Khalil, B., Dreifuss, F., Gauer, L. J., Leppik, I., & the United States Levetiracetam Study Group (2000) · Neurology · doi:10.1212/wnl.55.2.236 · Cited by 524
(2004) · Wiley eBooks · doi:10.1002/9780470752463 · Cited by 508
Evidence for a unique profile of levetiracetam in rodent models of seizures and epilepsy
Klitgaard, H., Matagne, A., Gobert, J., & Wülfert, E. (1998) · European Journal of Pharmacology · doi:10.1016/s0014-2999(98)00410-5 · Cited by 506
Shorvon, S. D., Löwenthal, A., Janz, D., Bielen, E., Loiseau, P., & for the European Levetiracetam Study Group (2000) · Epilepsia · doi:10.1111/j.1528-1157.2000.tb00323.x · Cited by 451
Ben‐Menachem, E., & Falter, U. (2000) · Epilepsia · doi:10.1111/j.1528-1157.2000.tb04605.x · Cited by 409
Mogens Dam (Chairman), R. E. (1989) · Epilepsy Research · doi:10.1016/0920-1211(89)90070-3 · Cited by 393
A double-blind, randomized trial of topiramate in Lennox–Gastaut syndrome
Sachdeo, R. C., Glauser, T. A., Ritter, F., Reife, R., Lim, P., Pledger, G., & the Topiramate YL Study Group (1999) · Neurology · doi:10.1212/wnl.52.9.1882 · Cited by 380
Lamotrigine for Generalized Seizures Associated with the Lennox–Gastaut Syndrome
Motte, J., Trevathan, E., Arvidsson, J. F. V., Barrera, M. N., Mullens, E. L., & Manasco, P. (1997) · New England Journal of Medicine · doi:10.1056/nejm199712183372504 · Cited by 359
White, H. S., Brown, S. D., Woodhead, J. H., Skeen, G. A., & Wolf, H. H. (1997) · Epilepsy Research · doi:10.1016/s0920-1211(97)00045-4 · Cited by 356
Standing, O. (2002) · Cited by 351
Rzany, B., Correia, O., Kelly, J. P., Naldi, L., Auquier, A., & Stern, R. (1999) · The Lancet · doi:10.1016/s0140-6736(98)05418-x · Cited by 348 · cited 1×
“However, a recent review of 73 cases of antiepileptic drug–related StevensJohnson syndrome and toxic epidermal necrolysis found lamotrigine to be associated with a lower relative risk comparedwithphenobarbital,phenytoin,and carbamazepine.(55) Subsequent review of published and unpublished clinical trial data showed th…”
Gibbs, J. W., Sombati, S., DeLorenzo, R. J., & Coulter, D. A. (2000) · Epilepsia · doi:10.1111/j.1528-1157.2000.tb02164.x · Cited by 348
The New Antiepileptic Drugs: A Systematic Review of Their Efficacy and Tolerability
Marson, A. G., Kadir, Z. A., Hutton, J. L., & Chadwick, D. W. (1997) · Epilepsia · doi:10.1111/j.1528-1157.1997.tb01251.x · Cited by 347
Lamotrigine‐Associated Rash: Risk/Benefit Considerations in Adults and Children
Guberman, A. H., Besag, F. M. C., Brodie, M. J., Dooley, J. M., Duchowny, M. S., Pellock, J. M., Richens, A., Stern, R. S., & Trevathan, E. (1999) · Epilepsia · doi:10.1111/j.1528-1157.1999.tb00807.x · Cited by 339
Privitera, M., Fincham, R., Penry, J., Reife, R., Kramer, L., Pledger, G., & Karim, R. (1996) · Neurology · doi:10.1212/wnl.46.6.1678 · Cited by 339
Outcomes of Add‐on Treatment with Lamotrigine in Partial Epilepsy
Smith, D., Baker, G., Davies, G., Dewey, M., & Chadwick, D. W. (1993) · Epilepsia · doi:10.1111/j.1528-1157.1993.tb02417.x · Cited by 330
A randomized, placebo-controlled study of topiramate in primary generalized tonic-clonic seizures
Biton, V., Montouris, G. D., Ritter, F., Riviello, J. J., Reife, R., Lim, P., Pledger, G., & the Topiramate YTC Study Group (1999) · Neurology · doi:10.1212/wnl.52.7.1330 · Cited by 295
Placebo‐controlled study of the efficacy and safety of lamotrigine in patients with partial seizures
Matsuo, F., Bergen, D., Faught, E., Messenheimer, J. A., Dren, A. T., Rudd, G. D., & Lineberry, C. G. (1993) · Neurology · doi:10.1212/wnl.43.11.2284 · Cited by 280
Suzdak, P. D., & Jansen, J. A. (1995) · Epilepsia · doi:10.1111/j.1528-1157.1995.tb02576.x · Cited by 278
Pharmacokinetics and metabolism of gabapentin in rat, dog and man.
Vollmer, K. O., von Hodenberg, A., & Kölle, E. U. (1986) · PubMed · Cited by 269
Zonisamide blocks T-type calcium channel in cultured neurons of rat cerebral cortex
Suzuki, S., Kawakami, K., Nishimura, S., Watanabe, Y., Yagi, K., Scino, M., & Miyamoto, K. (1992) · Epilepsy Research · doi:10.1016/0920-1211(92)90087-a · Cited by 268
Sodium valproate acutely inhibits lamotrigine metabolism.
Yuen, A., Land, G., Weatherley, B., & Peck, A. (1992) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.1992.tb04079.x · Cited by 252
Ben‐Menachem, E., Henriksen, O., Dam, M., Mikkelsen, M., Schmidt, D., Reid, S., Reife, R., Kramer, L., Pledger, G., & Karim, R. (1996) · Epilepsia · doi:10.1111/j.1528-1157.1996.tb00606.x · Cited by 243
Cost of Epilepsy in the United States: A Model Based on Incidence and Prognosis
Begley, C. E., Annegers, J. F., Lairson, D. R., Reynolds, T. F., & Hauser, W. A. (1994) · Epilepsia · doi:10.1111/j.1528-1157.1994.tb01794.x · Cited by 242
Zonisamide for add-on treatment of refractory partial epilepsy: a European double-blind trial
Schmidt, D., Jacob, R., Loiseau, P., Deisenhammer, E., Klinger, D., Despland, A., Egli, M., Bauer, G., Stenzel, E., & Blankenhorn, V. (1993) · Epilepsy Research · doi:10.1016/0920-1211(93)90011-u · Cited by 234
Betts, T., Waegemans, T., & Crawford, P. (2000) · Seizure · doi:10.1053/seiz.2000.0380 · Cited by 230
Oxcarbazepine Placebo‐Controlled, Dose‐Ranging Trial in Refractory Partial Epilepsy
(2000) · Epilepsia · doi:10.1111/j.1499-1654.2000.001597.x · Cited by 225
Randomized controlled trial of zonisamide for the treatment of refractory partial-onset seizures
Faught, E., Ayala, R., Montouris, G. G., Leppik, I. E., & the Zonisamide 922 Trial Group (2001) · Neurology · doi:10.1212/wnl.57.10.1774 · Cited by 222
Christe, W., Krämer, G., Vigonius, U., Pohlmann, H., Steinhoff, B. J., Brodie, M. J., & Moore, A. (1997) · Epilepsy Research · doi:10.1016/s0920-1211(96)01013-3 · Cited by 216
Bill, P. A., Vigonius, U., Pohlmann, H., Guerreiro, C. A. M., Kochen, S., Saffer, D., & Moore, A. (1997) · Epilepsy Research · doi:10.1016/s0920-1211(97)00024-7 · Cited by 216
Rosenfeld, W. E., Doose, D. R., Walker, S. A., & Nayak, R. K. (1997) · Epilepsia · doi:10.1111/j.1528-1157.1997.tb01123.x · Cited by 210
Gabapentin in partial epilepsy
Uk Gabapentin Study Group (1990) · The Lancet · doi:10.1016/0140-6736(90)91123-r · Cited by 209
A double-blind trial of gabapentin monotherapy for newly diagnosed partial seizures
Chadwick, D. W., Anhut, H., Greiner, M. J., Alexander, J., Murray, G. H., Garofalo, E. A., Pierce, M. W., & The International Gabapentin Monotherapy Study Group 945-77 (1998) · Neurology · doi:10.1212/wnl.51.5.1282 · Cited by 205
Lamotrigine for Generalized Seizures Associated with the Lennox–Gastaut Syndrome
Trevathan, E., Mullens, E. L., & Manasco, P. (1998) · New England Journal of Medicine · doi:10.1056/nejm199809173391218 · Cited by 194
Tassinari, C. A., Michelucci, R., Chauvel, P., Chodkiewicz, J., Shorvon, S., Henriksen, O., Dam, M., Reife, R., Pledger, G., & Karim, R. (1996) · Epilepsia · doi:10.1111/j.1528-1157.1996.tb00649.x · Cited by 190
Safety of Topiramate: Adverse Events and Relationships to Dosing
Shorvon, S. D. (1996) · Epilepsia · doi:10.1111/j.1528-1157.1996.tb06029.x · Cited by 184
Double-blind, placebo-controlled study of topiramate in patients with refractory partial epilepsy
Sharief, M., Viteri, C., Ben-Menachem, E., Weber, M., Reife, R., Pledger, G., & Karim, R. (1996) · Epilepsy Research · doi:10.1016/s0920-1211(96)00029-0 · Cited by 167
Induction of Ethinylestradiol and Levonorgestrel Metabolism by Oxcarbazepine in Healthy Women
Fattore, C., Cipolla, G., Gatti, G., Limido, G. L., Sturm, Y., Bernasconi, C., & Perucca, E. (1999) · Epilepsia · doi:10.1111/j.1528-1157.1999.tb00779.x · Cited by 165
McCabe, R. T., Wasterlain, C. G., Kucharczyk, N., Sofia, R. D., & Vogel, J. R. (1993) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)10138-9 · Cited by 156
Levetiracetam: The Preclinical Profile of a New Class of Antiepileptic Drugs?
Klitgaard, H. (2001) · Epilepsia · doi:10.1111/j.1528-1167.2001.00003.x · Cited by 153
Schapel, G. J., Beran, R. G., Vajda, F. J. E., Berkovic, S. F., Mashford, M. L., Dunagan, F. M., Yuen, W. C., & Davies, G. (1993) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.56.5.448 · Cited by 150
DeLorenzo, R. J., Sombati, S., & Coulter, D. A. (2000) · Epilepsia · doi:10.1111/j.1528-1157.2000.tb06048.x · Cited by 148
Tiagabine for Complex Partial Seizures
Uthman, B. M., Rowan, A. J., Ahmann, P. A., et al. (1998) · Archives of Neurology · doi:10.1001/archneur.55.1.56 · Cited by 146
Oxcarbazepine: Mechanisms of Action
McLean, M. J., Schmutz, M., Wamil, A. W., et al. (1994) · Epilepsia · doi:10.1111/j.1528-1157.1994.tb05949.x · Cited by 144
Comparison of oxcarbazepine and carbamazepine: a double-blind study
Reinikainen, K. J., Keränen, T., Halonen, T., Komulainen, H., & Riekkinen, P. J. (1987) · Epilepsy Research · doi:10.1016/0920-1211(87)90003-9 · Cited by 143
A Neuropharmacological Evaluation of Felbamate as a Novel Anticonvulsant
White, H. S., Wolf, H. H., Swinyard, E. A., Skeen, G. A., & Sofia, R. D. (1992) · Epilepsia · doi:10.1111/j.1528-1157.1992.tb01711.x · Cited by 142
Differential Cognitive Effects of Carbamazepine and Gabapentin
Meador, K. J., Loring, D. W., Ray, P. G., Murro, A. M., King, D. W., Nichols, M., Deer, E. M., & Goff, W. T. (1999) · Epilepsia · doi:10.1111/j.1528-1157.1999.tb00858.x · Cited by 135
Lack of enzyme induction with oxcarbazepine (600 mg daily) in healthy subjects.
Larkin, J., McKee, P., Forrest, G., Beastall, G. H., Park, B., Lowrie, J. I., Lloyd, P. M., & Brodie, M. J. (1991) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.1991.tb03858.x · Cited by 119
Adverse Reactions to New Anticonvulsant Drugs
Wong, I. C. K., & Lhatoo, S. D. (2000) · Drug Safety · doi:10.2165/00002018-200023010-00003 · Cited by 118
Richens, A. (1994) · Epilepsia · doi:10.1111/j.1528-1157.1994.tb05965.x · Cited by 114
Tiagabine Therapy for Complex Partial Seizures
Sachdeo, R. C. (1997) · Archives of Neurology · doi:10.1001/archneur.1997.00550170069016 · Cited by 111
Nieto-Barrera, M., Brozmanová, M., Capovilla, G., Christe, W., Pedersen, B., Kane, K., & O'Neill, F. (2001) · Epilepsy Research · doi:10.1016/s0920-1211(01)00271-6 · Cited by 108
Tiagabine-induced absence status in idiopathic generalized epilepsy
Knake, S., Hamer, H. M., Schomburg, U., Oertel, W. H., & Rosenow, F. (1999) · Seizure · doi:10.1053/seiz.1999.0303 · Cited by 101
Nonconvulsive Status Epilepticus in Two Patients Receiving Tiagabine Treatment
Eckardt, K. M., & Steinhoff, B. J. (1998) · Epilepsia · doi:10.1111/j.1528-1157.1998.tb01438.x · Cited by 78
Yen, D., Yu, H., Guo, Y., Chen, C., Yiu, C., & Su, M. (2000) · Epilepsia · doi:10.1111/j.1528-1157.2000.tb00321.x · Cited by 68
Levetiracetam: The Preclinical Profile of a New Class of Antiepileptic Drugs?
Klitgaard, H. (2001) · Epilepsia · doi:10.1046/j.1528-1157.2001.00003.x · Cited by 68
Marketed New Antiepileptic Drugs: Are They Better Than Old-Generation Agents?
Perucca, E. (2002) · Therapeutic Drug Monitoring · doi:10.1097/00007691-200202000-00013 · Cited by 65
Absence of interaction between oxcarbazepine and erythromycin
Keränen, T., Jolkkonen, J., Pk, J., et al. (1992) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.1992.tb05051.x · Cited by 62
The efficacy of felbamate as add-on therapy to valproic acid in the Lennox–Gastaut syndrome
Siegel, H. E., Kelley, K., Stertz, B., Reeves‐Tyer, P., Flamini, R. J., Malow, B. A., Gaillard, W. D., Ko, D., & Theodore, W. H. (1999) · Epilepsy Research · doi:10.1016/s0920-1211(98)00119-3 · Cited by 47
Baulac, M. (1998) · Seizure · doi:10.1016/s1059-1311(98)90009-7 · Cited by 45
No Increase in Carbamazepine-10,11-Epoxide During Addition of Lamotrigine Treatment in Children
Eriksson, A.-S., & Boréus, L. O. (1997) · Therapeutic Drug Monitoring · doi:10.1097/00007691-199710000-00002 · Cited by 20
Cited by
The Endocannabinoid System as an Emerging Target of Pharmacotherapy
Pacher, P., Bátkai, S., & Kunos, G. (2006) · Pharmacological Reviews · doi:10.1124/pr.58.3.2 · Cited by 2,077
“Conventional antiepileptic treatment is not fully effective in ~30% of patients, therefore justifying the search for new targets (LaRoche and Helmers, 2004).”
BackgroundSLC6 Neurotransmitter Transporters: Structure, Function, and Regulation
Kristensen, A. S., Andersen, J., Jørgensen, T. N., Sørensen, L., Eriksen, J., Loland, C. J., Strømgaard, K., & Gether, U. (2011) · Pharmacological Reviews · doi:10.1124/pr.108.000869 · Cited by 864
Picot, M., Baldy‐Moulinier, M., Daurès, J., Dujols, P., & Crespel, A. (2008) · Epilepsia · doi:10.1111/j.1528-1167.2008.01579.x · Cited by 455
Vinik, A. I., Nevoret, M.-L., Casellini, C., & Parson, H. (2013) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2013.06.001 · Cited by 366
Autonomic alterations and cardiac changes in epilepsy
Sevcencu, C., & Struijk, J. J. (2010) · Epilepsia · doi:10.1111/j.1528-1167.2009.02479.x · Cited by 298
Metadata
- Authors
- LaRoche, S. M., & Helmers, S. L.
- Venue
- JAMA
- Publisher
- American Medical Association (AMA)
- Published
- 2004-02-04
- Volume
- 291
- Issue
- 5
- Pages
- 605
- ISSN
- 0002-9955 (ISSN-L)
- 0098-7484
- OpenAlex
- W2013782010
- Cited by
- 279
- References
- 67
- FWCI
- 19.88
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.